Joseph Jenrette to Humans
This is a "connection" page, showing publications Joseph Jenrette has written about Humans.
Connection Strength
0.291
-
Rosai-Dorfman disease: management of CNS and systemic involvement. Clin Adv Hematol Oncol. 2012 Mar; 10(3):199-202.
Score: 0.016
-
Central nervous system myelomatosis with optic neuropathy and intramedullary spinal cord compression responding to radiation therapy. Jpn J Radiol. 2011 Aug; 29(7):513-6.
Score: 0.015
-
Radiation therapy for B-cell cutaneous lymphoid hyperplasia. Jpn J Radiol. 2010 Jun; 28(5):385-7.
Score: 0.014
-
Six-year experience: long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy. Am J Surg. 2010 Feb; 199(2):204-9.
Score: 0.013
-
High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas. J Neurooncol. 2009 Jul; 93(3):343-8.
Score: 0.013
-
Helical tomotherapy for total lymphoid irradiation. Radiat Med. 2008 Dec; 26(10):622-6.
Score: 0.013
-
Late chest wall toxicity after MammoSite breast brachytherapy. Brachytherapy. 2009 Jan-Mar; 8(1):19-25.
Score: 0.012
-
Patient satisfaction and quality of life after MammoSite breast brachytherapy. Am J Surg. 2008 Oct; 196(4):545-8.
Score: 0.012
-
A case of orbital Rosai-Dorfman disease responding to radiotherapy. J Pediatr Hematol Oncol. 2008 Oct; 30(10):744-8.
Score: 0.012
-
Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy. Brachytherapy. 2008 Oct-Dec; 7(4):305-9.
Score: 0.012
-
The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma. Eur J Obstet Gynecol Reprod Biol. 2008 Dec; 141(2):163-8.
Score: 0.012
-
Radiation therapy for palliation of Eisenmenger's syndrome-associated painful splenomegaly. Radiat Med. 2008 Feb; 26(2):84-7.
Score: 0.012
-
Definitive radiotherapy for medically inoperable early-stage serous and clear cell uterine carcinoma. Radiat Med. 2007 Dec; 25(10):536-40.
Score: 0.012
-
Delayed skin toxicity in MammoSite breast brachytherapy. Am J Clin Oncol. 2006 Dec; 29(6):645-6.
Score: 0.011
-
Chest wall dose in MammoSite breast brachytherapy: radiobiologic estimations of late complication risk based on dose-volume considerations. Brachytherapy. 2005; 4(4):259-63.
Score: 0.009
-
Management of treatment-resistant cutaneous sarcoidosis with radiation. Am J Clin Oncol. 2002 Dec; 25(6):573-5.
Score: 0.008
-
Radiotherapy-induced reactivation of neurotrophic human herpes viruses: Overview and management. J Clin Virol. 2018 01; 98:18-27.
Score: 0.006
-
Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539. J Neurosurg. 2018 07; 129(1):35-47.
Score: 0.006
-
Malignant melanoma: the role of radiation therapy revisited. Semin Oncol. 1996 Dec; 23(6):759-62.
Score: 0.005
-
Pediatric Patients Demonstrate Progressive T1-Weighted Hyperintensity in the Dentate Nucleus following Multiple Doses of Gadolinium-Based Contrast Agent. AJNR Am J Neuroradiol. 2016 Dec; 37(12):2340-2347.
Score: 0.005
-
Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. Neuro Oncol. 2016 Apr; 18(4):565-74.
Score: 0.005
-
Comparison of radiation dose spillage from the Gamma Knife Perfexion with that from volumetric modulated arc radiosurgery during treatment of multiple brain metastases in a single fraction. J Neurosurg. 2014 Dec; 121 Suppl:51-9.
Score: 0.005
-
Prostate cancer: the role of radiation therapy. J S C Med Assoc. 1994 May; 90(5):222-4.
Score: 0.005
-
Ultrasound-guided tandem placement for low-dose-rate brachytherapy in advanced cervical cancer minimizes risk of intraoperative uterine perforation. Ultrasound Obstet Gynecol. 2011 Feb; 37(2):241-4.
Score: 0.004
-
Glioneuronal tumor with neuropil-like islands of the spinal cord with diffuse leptomeningeal neuraxis dissemination. J Neurooncol. 2011 Sep; 104(2):529-33.
Score: 0.004
-
Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):21-9.
Score: 0.004
-
A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme. J Neurosurg. 2010 Aug; 113(2):192-8.
Score: 0.003
-
Successful treatment of late, recurrent wilms tumor with high-dose chemotherapy and autologous stem cell rescue in third complete response. J Pediatr Hematol Oncol. 2010 Aug; 32(6):e241-3.
Score: 0.003
-
Helical tomotherapy for extramedullary hematopoiesis involving the pericardium in a patient with chronic myeloid leukemia. Jpn J Radiol. 2010 Jul; 28(6):476-8.
Score: 0.003
-
Mammographic surveillance after MammoSite breast brachytherapy: analysis of architectural patterns and additional interventions. Am J Clin Oncol. 2007 Dec; 30(6):574-9.
Score: 0.003
-
Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-year results. Int J Radiat Oncol Biol Phys. 2008 May 01; 71(1):107-14.
Score: 0.003
-
Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys. 2007 Jun 01; 68(2):354-8.
Score: 0.003
-
GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis. Neurosurgery. 2006 Apr; 58(4):701-9; discussion 701-9.
Score: 0.003
-
Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience. Int J Radiat Oncol Biol Phys. 2005 Jan 01; 61(1):169-74.
Score: 0.002
-
Outcome of radiation therapy for renal transplant rejection refractory to chemical immunosuppression. Radiother Oncol. 2005 Jan; 74(1):17-9.
Score: 0.002
-
Skin toxicity during breast irradiation: pathophysiology and management. South Med J. 2004 Oct; 97(10):989-93.
Score: 0.002
-
Vulvar cancer in a patient with Fanconi's anemia, treated with 3D conformal radiotherapy. Am J Hematol. 2004 Jun; 76(2):148-51.
Score: 0.002
-
Fetal dose during radiotherapy: clinical implementation and review of the literature. Cancer Radiother. 2002 Dec; 6(6):352-7.
Score: 0.002
-
Desmoid tumors in a woman with idiopathic multicentric osteolysis: result of three etiologic factors or coincidence? Am J Clin Oncol. 2000 Aug; 23(4):376-8.
Score: 0.002
-
Interparenchymal hemorrhagic neurocytoma: an atypical presentation of a rare CNS tumor. Med Pediatr Oncol. 1999 Jun; 32(6):440-6.
Score: 0.002
-
Dynamic stereotactic radiosurgery: the Charleston program: a report on the first 150 patients. J S C Med Assoc. 1998 May; 94(5):218-21.
Score: 0.001
-
Survival with combined modality therapy after intracerebral recurrence of pleuropulmonary blastoma. Med Pediatr Oncol. 1998 Jan; 30(1):63-6.
Score: 0.001
-
Multi-disciplinary approach to cranial base tumors. J S C Med Assoc. 1994 Oct; 90(10):450-4.
Score: 0.001
-
Combined modality therapy in the treatment of epidermoid carcinoma of the anus at the Medical University of South Carolina. J S C Med Assoc. 1993 Jul; 89(7):333-6.
Score: 0.001
-
Dynamic stereotactic radiosurgery using a linear accelerator. South Med J. 1991 Nov; 84(11):1327-33.
Score: 0.001
-
Primary malignant extragonadal germ cell tumors. An analysis of the effect of the effect of radiotherapy. Cancer. 1990 Jun 15; 65(12):2681-5.
Score: 0.001
-
Intraperitoneal P-32 after negative second-look laparotomy in ovarian carcinoma. Cancer. 1989 Jun 15; 63(12):2434-7.
Score: 0.001
-
Primary central nervous system germ cell tumors. Effect of histologic confirmation on radiotherapy. Cancer. 1988 Jun 01; 61(11):2148-52.
Score: 0.001
-
The management of early breast cancer (clinical stage I). J S C Med Assoc. 1988 May; 84(5):231-3.
Score: 0.001
-
Radiation enteritis. Am Surg. 1987 Sep; 53(9):501-4.
Score: 0.001
-
Primary malignant mediastinal germ-cell tumors and the contribution of radiotherapy: a southeastern multi-institutional study. Am J Clin Oncol. 1987 Aug; 10(4):302-6.
Score: 0.001
-
Epidermoid carcinoma of the anus. Surg Gynecol Obstet. 1982 Nov; 155(5):745-51.
Score: 0.001